|
|
Article: Intranasal corticosteroids for first-line treatment of allergic rhinitis: What's the evidence?
- Article from:
- Formulary
- Article date:
- April 1, 2001
- Author:
CopyrightCopyright Advanstar Communications, Inc. Apr 2001. Provided by ProQuest LLC. (Hide copyright information)
|
ABSTRACT
Treatment of allergic rhinitis includes avoidance of allergens and, in many patients, prescription medications to control symptoms. Antihistamines are considered by guidelines to be first-line therapy for most patients, largely due to their perceived advantage in onset of action. However, firstgeneration antihistamines are associated with undesirable sedative effects and second-generation antihistamines are relatively costly. Intranasal corticosteroids (INCS), traditionally reserved for severe allergic rhinitis, have been emerging as a first-line therapy in patients with milder disease. The INCS are considered by guidelines to be the most effective treatment for the symptoms of ...